|
MechanismNMDA receptor antagonists [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismB2 receptor antagonists |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismOpioid receptors agonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Nova Pharmaceutical, Inc. (Maryland)
0 Patents (Medical) associated with Nova Pharmaceutical, Inc. (Maryland)
100 Deals associated with Nova Pharmaceutical, Inc. (Maryland)
100 Translational Medicine associated with Nova Pharmaceutical, Inc. (Maryland)